|








| |
Antimicrobial Agents and Chemotherapy, June 2004, p . 2308-2313, Vol . 48, No . 6
High-Level Resistance to Ceftazidime Conferred by a Novel Enzyme, CTX-M-32, Derived from CTX-M-1 through a Single Asp240-Gly Substitution
Monica Cartelle, Maria del Mar Tomas, Francisca Molina, Rita Moure, Rosa Villanueva, and German Bou*
Servicio de Microbiologia, Complejo Hospitalario Universitario Juan Canalejo, 15006 La Coruña, Spain
Received 27 June 2003/
Returned for modification 8 September 2003/
Accepted 13 February 2004
A clinical strain of Escherichia coli isolated from pleural liquid with high levels of resistance to cefotaxime, ceftazidime, and aztreonam harbors a novel CTX-M gene (blaCTX-M-32) whose amino acid sequence differs from that of CTX-M-1 by a single Asp240-Gly substitution . Moreover, by site-directed mutagenesis we demonstrated that this replacement is a key event in ceftazidime hydrolysis
The emergence of plasmid-mediated extended-spectrum ß-lactamases in members of the family Enterobacteriaceae has become a worldwide problem (3, 4, 6, 7, 11-13, 16) .
Most extended-spectrum ß-lactamases are derivatives of TEM-1, TEM-2, or SHV-1 enzymes; however, there are an increasing number of reports that describe the worldwide emergence of ß-lactamases belonging to other families, such as CTX-M and/or OXA derivatives (8) .
The family of CTX-M enzymes is grouped on the basis of similarities in amino acid sequences into four major phylogenetic trees (6): the CTX-M-1 group (CTX-M-1 or MEN-1, CTX-M-3, CTX-M-10, CTX-M-12, CTX-M-15, and now CTX-M-32), the CTX-M-2 group (CTX-M-2, CTX-M-4, CTX-M-5, CTX-M-6, CTX-M-7, CTX-20, and Toho-1), the CTX-M-8 group, and the CTX-M-9 group (CTX-M-9, CTX-M-13, CTX-M-14, CTX-M-16, CTX-M-18, CTX-M-19, CTX-M-21, and Toho-2) . The designation CTX-M refers to a potent activity against cefotaxime and having only a remnant of activity toward ceftazidime .
Here we report the molecular characterization of a new CTX-M ß-lactamase derived from CTX-M-1 through a single Asp240-Gly substitution, CTX-M-32 . In addition, we report experimental data showing that substitution of this amino acid is itself sufficient to confer hydrolytic activity against ceftazidime .
Patterns of antibiotic susceptibility shown by the clinical strain E . coli JC19325, as well as its transconjugant and transformants, are shown in Table 1 . The MICs were determined by E-test and interpreted according to the method of the National Committee for Clinical Laboratory Standards (18) . The clinical strain JC19325 showed a high level of resistance to cefotaxime, ceftazidime, and aztreonam (MICs of >256 µg/ml), cefoxitin (MIC of >256 µg/ml), and cefepime (MIC of 64 µg/ml) . Moreover, clavulanic acid acted synergistically with amoxicillin, cefotaxime, and ceftazidime (E-test; ABBiodisk, Solna, Sweden), thus indicating the presence of a class A ß-lactamase (9) . An Escherichia coli TG1 transformant harboring the pMC-2 plasmid showed higher MICs of the affected antibiotics, probably due to more copies of the bla gene .
|
TABLE 1 . MICs of ß-lactams for the JC19325 clinical strain, E . coli XL1(pMC-1), E . coli TG1, E . coli TG1(pMC-2), and E . coli TG1(pMC-3)
|
|
Isoelectric focusing was performed using polyacrylamide gels containing Ampholine, within a pH range of 3.5 to 9.5, as previously described (17) . The clinical isolate produced one enzyme with a pI of 9.0 .
In the present study the E . coli XL1-Blue MRF'Kan strain (Stratagene Europe, Amsterdam, The Netherlands) was used in the conjugation experiments .
The clinical strain JC19325 had one plasmid which harbored a ß-lactamase with a pI of 9.0 that was transferred by conjugation into E . coli XL1-Blue MRF'Kan using kanamycin (25 µg/ml) and cefotaxime (2 µg/ml) as selective antibiotics . A few of the transconjugants which grew harbored an identical plasmid of approximately 15 kb, which was named pMC-1 .
Plasmid DNA was isolated by the alkaline lysis method (23) from the transconjugant that produced a single ß-lactamase with a pI of 9.0 . Plasmid DNA was digested with KpnI and ligated to the plasmid vector pBGS18 (25); afterwards, the ligation mixture was introduced into E . coli TG1 cells by transformation with CaCl2, and transformants were detected on Luria-Bertani agar plates with cefotaxime (2 µg/ml) and kanamycin (25 µg/ml) . The resulting plasmid, designated pMC-2, carried a bla-producing insert of size circa 4 kb . Double-stranded templates were subjected to nucleotide sequencing by using the method of Sanger et al . (23, 23a) .
During isoelectric focusing, the pI 9.0 ß-lactamase activity band from the E . coli transformants cofocused with the ß-lactamase activity band from the clinical strain JC19325 . Nucleotide sequencing of the KpnI insert revealed some interesting features, including (i) a new bla gene . This new bla gene was 876 bp long, initiated with an ATG codon, and ended with a TGA codon (291 amino acids long) . The initiation codon was preceded by a Shine-Dalgarno ribosome-binding sequence, AAGGAA . The EMBL and Swiss-Prot database searches for this open reading frame revealed similarities to CTX-M ß-lactamases . The deduced amino acid sequence had the closest homology (99%) with the CTX-M-1 enzyme (2, 3), from which it differed by the single amino acid substitution Asp240-Gly (Ambler numbering) (1) . (ii) The second interesting feature was the inverted repeat right (IRR) sequence of ISEcp1B 80 bp upstream of the ATG start codon of CTX-M-32 . No putative promoter sequences were found in the 80-bp sequence that separated the IRR of ISEcp1B from the ATG site of the blaCTX-M-32 gene; moreover, this IRR provided 35 and 10 promoter sequences, thus probably contributing to the expression of the blaCTX-M-32 gene . (iii) Third, this IRR was downstream of a tnpA gene that encoded the transposase of IS5 . Figure 1 shows the 2,326-bp sequence of the original 4-kpb KpnI fragment .
To purify the CTX-M enzyme, the blaCTX-M-32 gene was cloned in the pGEX-6P-1 vector, which allowed a fusion protein between glutathione S-transferase (GST) and the CTX-M enzyme . The ß-lactamase was purified to homogeneity following the manufacturer's directions for the GST gene fusion system (Amersham Pharmacia Biotech, Europe GmbH) . The purified protein appeared on sodium dodecyl sulfate-polyacrylamide gel electrophoresis as a band of 28 kDa ( 99% pure) (Fig . 2) .
|
FIG . 2 . Electrophoresis analysis of CTX-M-32 and CTX-M-1 purified extracts in a sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis gel stained with Coomassie brilliant blue R-250 . Lanes: 1, protein molecular markers; 2, purified CTX-M-1 protein used in kinetic experiments; 3, purified CTX-M-32 protein used in kinetic experiments.
|
|
For kinetic experiments, CTX-M-32 ß-lactamase was used at a 1,800 µM concentration . The ß-lactamase showed a hydrolytic profile similar to that expected for a molecular class A CTX-M enzyme (6), with the Km for ampicillin lower than the Km for cefalothin, a Km for cefotaxime of <500 µM, and a clear hydrolytic activity towards cefotaxime . Moreover, moderate hydrolytic activity was detected against ceftazidime, as ceftazidime MICs suggested (Table 2) .
|
TABLE 2 . Substrate profile of ß-lactamase CTX-M-32
|
|
The CTX-M-32 enzyme is derived from CTX-M-1 by a single amino acid replacement, Asp240-Gly . To confirm the importance of the Asp-Gly substitution in the hydrolysis of ceftazidime, we replaced the Gly240 with Asp in CTX-M-32 by using site-directed mutagenesis as previously described (14) . The CTX-M-32mut or CTX-M-1 gene was then cloned into the pBGS18 vector, yielding the pMC-3 plasmid . The mutagenesis was confirmed by nucleotide sequencing . The MICs for E . coli TG1 harboring pMC-2 and pMC-3 are shown in Table 1 . The MICs of ceftazidime corresponding to E . coli TG1 harboring CTX-M-1 ß-lactamase were clearly lower than those corresponding to E . coli TG1 carrying CTX-M-32 . To confirm this result, the substrate profile of the CTX-M-1 ß-lactamase was determined with the enzyme purified as mentioned above for CTX-M-32 (GST gene fusion system) (Fig . 2) . For kinetic experiments, CTX-M-1 ß-lactamase was used at a 1,670 µM concentration . Kcat/Km (in micromolar per second) values for ceftazidime and cefotaxime were 0.0001 and 1.5; therefore, a lower catalytic efficiency with respect to ceftazidime was detected with CTX-M-1, according to the differences in ceftazidime MICs between CTX-M-32 and CTX-M-1 enzymes (Table 1) .
Three different enzymes, CTX-M-15, -16, -19 and, recently, CTX-M-27 have been reported to be associated with ceftazidime hydrolysis (4, 5, 20, 21) . The amino acid changes associated with the phenotype of ceftazidime hydrolysis were a Pro-to-Ser substitution at position 167 in CTX-M-19 with respect to CTX-M-18 (20) and an Asp-to-Gly substitution at position 240 in CTX-M-16 with respect to CTX-M-9 (4) and in CTX-M-27 with respect to CTX-M-14 (5) . In agreement with these previous results, we also report that the Asp240 substitution is a key factor in the evolution of CTX-M ß-lactamases, as it increases their hydrolytic activity toward ceftazidime .
Regarding the CTX-M enzymes, to our knowledge only six different enzymes have been published in the group 1 CTX-M enzymes: CTX-M-1, -3, -10, -12, -15, and -32 (3, 16, 19, 20) . Among these, only CTX-M-15 and -32 showed more efficient ceftazidime hydrolysis than their parental enzymes, CTX-M-3 and CTX-M-1, respectively . The two former enzymes share the same amino acid substitution, although CTX-M-15 differs from CTX-M-32 in four additional amino acid changes . In terms of evolution, CTX-M-32 is probably an ancestor between CTX-M-1 and CTX-M-15 and constitutes a step forward in the evolution of ß-lactamase in broad-spectrum hydrolysis of antibiotics such as ceftazidime .
In summary, we report the genetic and biochemical characterization of a new CTX-M enzyme, CTX-M-32 . This is the fourth report of a CTX-M ß-lactamase isolation in Spain, as CTX-M-9, CTX-M-10, and CTX-M-14 have previously been isolated in this country (7, 19, 22, 24) .
Nucleotide sequence accession number.
The GenBank accession number for the CTX-M-32 ß-lactamase is AJ557142 .
. .
This work was supported by Direccion Xeral de I+D, Xunta de Galicia (PGIDT01PXR90101PR and PGIDIT02SAN91604PR) and Fondo de Investigaciones Sanitarias (PI021415) .
* Corresponding author . Mailing address: Servicio de Microbiologia, Complejo Hospitalario Universitario Juan Canalejo, C/Xubias de Arriba s/n, 15006 La Coruña, Spain . Phone: 981-178000, ext . 21144 . Fax: 981-178216 . E-mail: germanbou{at}canalejo.org .
- Ambler, R . P., A . F . W . Coulson, J . M . Frere, J . M . Ghuysen, B . Joris, M . Forsman, et al. 1991 . A standard numbering scheme for the class A ß-lactamases . Biochem . J . 276:269-270.
- Barthélémy, M., J . Péduzzi, H . Bernard, C . Tancrède, and R . Labia. 1992 . Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum ß-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochim . Biophys . Acta 1122:15-22.
- Bauernfeind, A., I . Stemplinger, R . Jungwirth, S . Ernst, and J . M . Casellas. 1996 . Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases . Antimicrob . Agents Chemother . 40:509-513.
- Bonnet, R., C . Dutour, J . L . Samapaio, C . Chanal, D . Sirot, R . Labia, C . D Champs, and J . Sirot. 2001 . Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-Gly . Antimicrob . Agents Chemother . 45:2269-2275.
- Bonnet, R., C . Recule, R . Baraduc, C . Chanal, D . Sirot, C . De Champs, and J . Sirot. 2003 . Effect of D240G substitution in a novel ESBL CTX-M-27 . J . Antimicrob . Chemother . 52:29-35.
- Bonnet, R., J . L . Sampaio, R . Labia, C . De Champs, D . Sirot, C . Chanal, and J . Sirot. 2000 . A novel CTX-M ß-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil . Antimicrob . Agents Chemother . 44:1936-1942.
- Bou, G., M . Cartelle, M . Tomas, D . Canle, F . Molina, R . Moure, J . M . Eiros, and A . Guerrero. 2002 . Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain . J . Clin . Microbiol . 40:4030-4036.
- Bradford, P . A. 2001 . Extended-spectrum ß-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistant threat . Clin . Microbiol . Rev . 14:933-951.
- Bush, K., G . A . Jacoby, and A . A . Medeiros. 1995 . A functional classification scheme for ß-lactamases and its correlation with molecular structure . Antimicrob . Agents Chemother . 39:1211-1233.
- Cao, V., T . Lambert, and P . Courvalin. 2002 . ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum ß-lactamase CTX-M-17 . Antimicrob . Agents Chemother . 46:1212-1217.
- Chanawong, A., F . H . M'Zali, J . Heritage, J . H . Xiong, and P . M . Hawkey. 2002 . Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China . Antimicrob . Agents Chemother . 46:630-637.
- Coque, T . M., A . Oliver, J . C . Pérez-Díaz, F . Baquero, and R . Cantón. 2002 . Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum ß-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000) . Antimicrob . Agents Chemother . 46:500-510.
- Dutour, C., R . Bonnet, H . Marchandin, M . Boye, C . Chanal, D . Sirot, and J . Sirot. 2002 . CTX-M-1, CTX-M-3, and CTX-M-14 ß-lactamases from Enterobacteriaceae isolated in France . Antimicrob . Agents Chemother . 46:534-537.
- Ho, S . N., H . D . Hunt, R . M . Horton, J . K . Pullen, and L . R . Pease. 1989 . Site-directed mutagenesis by overlap extension using the polymerase chain reaction . Gene 77:51-59.
- Joris, B., P . Ledent, O . Dideberg, E . Fonze, J . Lamotte-Brasseur, J . A . Kelly, J . M . Ghuysen, and J . M . Frere. 1991 . Comparison of the sequences of class A ß-lactamases and of the secondary structure elements of penicillin-recognizing proteins . Antimicrob . Agents Chemother . 35:2294-2301.
- Kariruki, S., J . E . Corkill, G . Revathi, R . Musoke, and C . A . Hart. 2001 . Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya . Antimicrob . Agents Chemother . 45:2141-2143.
- Matthew, M., A . M . Harris, M . J . Marshall, and G . W . Ross. 1975 . The use of analytical isoelectric focusing for detection and identification of ß-lactamases . J . Gen . Microbiol . 88:169-178.
- National Committee for Clinical Laboratory Standards. 2003 . Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically . Approved standard M7-A6 . National Committee for Clinical Laboratory Standards, Wayne, Pa.
- Oliver, A., J . C . Pérez-Díaz, T . M . Coque, F . Baquero, and R . Cantón. 2001 . Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing ß-lactamase (CTX-M-10) isolated in Spain . Antimicrob . Agents Chemother . 45:616-620.
- Poirel, L., M . Gniadkowski, and P . Nordmann. 2002 . Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3 . J . Antimicrob . Chemother . 50:1031-1034.
- Poirel, L., T . Naas, I . Le Thomas, A . Karim, E . Bingen, and P . Nordmann. 2001 . CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop . Antimicrob . Agents Chemother . 45:3355-3361.
- Sabate, M., R . Tarrago, F . Navarro, E . Miro, C . Verges, J . Barbe, and G . Prats. 2000 . Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain . Antimicrob . Agents Chemother . 44:1970-1973.
- Sambrook, J., E . F . Fritsch, and T . Maniatis. 1989 . Molecular cloning: a laboratory manual, 2nd ed . Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
- Sanger, F., S . Nicklen, and A . R . Coulson. 1977 . DNA sequencing with chain-terminating inhibitors . Proc . Natl . Acad . Sci . USA 74:5463-5467.
- Simarro, E., F . Navarro, J . Ruiz, E . Miro, J . Gomez, and B . Mirelis. 2000 . Salmonella enterica serovar Virchow with CTX-M-like beta-lactamase in Spain . J . Clin . Microbiol . 38:4676-4678.
- Spratt, B., P . J . Hedge, T . S . Heesen, A . Edelman, and J . K . Broome-Smith. 1986 . Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8, and pEMBL9 . Gene 41:337-342.
Free Online Full-text Article
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
|